Do antibody CDR loops change conformation upon binding?
Antibodies have increasingly been developed as drugs with over 100 now licensed in the US or EU. During development, it is often necessary to increase or reduce the affinity of an antibody and rational attempts to do so rely on having a structure of the antibody-antigen complex often obtained by mod...
Saved in:
| Main Authors: | Chu’nan Liu, Lilian M. Denzler, Oliver E.C. Hood, Andrew C.R. Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | mAbs |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2322533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies
by: Oscar Mejias-Gomez, et al.
Published: (2023-12-01) -
Identification of unique binding mode anti-NTF3 antibodies from a novel long VH CDR3 phage display library
by: Stacey E. Chin, et al.
Published: (2025-03-01) -
50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations
by: Zirui Zhu, et al.
Published: (2024-12-01) -
Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability
by: Wei-Ching Liang, et al.
Published: (2024-12-01) -
Contribution of CDR3 in characterization of camelid VHH and its aflatoxin B1-binding interaction
by: Hina Mukhtar, et al.
Published: (2025-03-01)